Portfolio (Quarterly)
Guide ↗
REGENERON PHARMACEUTICALS, INC.
· CIK 0000872589| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NTLA | Intellia Therapeutics, Inc. | Healthcare | 3,702,995.0 | $47.5M | 99.14% | — | — | $12.82 | +22.2% |
| 2 | ACET | Adicet Bio, Inc. | Healthcare | 60,511.0 | $412K | 0.86% | — | — | $6.81 | +18.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%